Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
ophthalmology
Biotech
Lilly bags eye-catching gene therapy in $475M deal
The Indiana drugmaker will gain rights to a gene therapy that has restored vision in 11 children born legally blind.
Darren Incorvaia
Nov 10, 2025 7:00am
Italian biotech raises $141M series B to fund eye gene therapies
Nov 3, 2025 3:00am
Science's retinal implant restores some vision in AMD patients
Oct 21, 2025 6:50am
I-Mab unveils new name, strategy, asset and Hong Kong IPO plans
Oct 17, 2025 10:45am
AviadoBio secures option to rare eye disease gene therapy
Oct 9, 2025 8:50am
Eye disease biotech launches with $100M, Roche rival in clinic
Sep 17, 2025 6:30am